By |

Equities News

Company chart and information is provided by TradingView based on 15-minute-delayed data.


Profile

Novavax Inc is a biotechnology company that develops vaccines. The company works in the clinical stage of development with a focus on delivering novel products that prevent a broad range of diseases. Novavax works together with its wholly owned Swedish subsidiary to produce vaccine candidates to respond to both known and emerging disease threats. The company believes its vaccine technology has the potential to be applied broadly to a wide variety of human infectious diseases. Novavax develops product candidates geared toward all age demographics of the general population.

Contact Information

Website: www.novavax.com
Email: ir@novavax.com
Main Phone: +1 240 268-2000
Address: 21 Firstfield Road
Address 2: Suite 1188, Bentall 5
State: MD
City / Town: Gaithersburg
Country: US
Postal Code: 20878

Issuer Information

Exchange: NGS
CEO: Stanley Charles Erck
Employees: 791
NAICS: Biological Product (except Diagnostic) Manufacturing(325414)

Equities News

View More
(%)
Company data no longer available
Last Price N/A Change $ N/A Change % N/A Tick N/A
Bid N/A Bid Size N/A Ask N/A Ask Size N/A
Open N/A High N/A Low N/A Prev Close N/A
Last Trade Volume N/A 52 Wk Hi N/A 52 Wk Low N/A
Market Cap N/A Ex-Div Date N/A Div Rate N/A Yield N/A
Shares N/A EPS (TTM) N/A PE Ratio N/A Exchange N/A